Skip to content

Friday, 13 November 2026 IST

EN हिं
Breaking
India confirms invitations to SCO members for Civilisational Dialogue in New Delhi India confirms invitations to SCO members for Civilisational Dialogue in New Delhi
Health Summary

India rejects patent bid for treatment of drug-resistant TB

Civil society groups urge U.S.-based Global Alliance for TB Drug Development to withdraw related patent claims in other countries 

By Storywire Newsdesk Published Updated
Share on X Facebook WhatsApp LinkedIn
Indian Patent Office rejects patent application for drug-resistant TB regimen
Indian Patent Office rejects patent application for drug-resistant TB regimen — image via The Hindu Health feed — Credit: Storywire

Attributed summary

Civil society groups urge U.S.-based Global Alliance for TB Drug Development to withdraw related patent claims in other countries 

Read the original report — The Hindu Health

Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.

Corrections